Status:
COMPLETED
PRPP Model for Evaluation the Effect of Non-pharmaceutical Therapies
Lead Sponsor:
Beijing University of Chinese Medicine
Conditions:
Fibromyalgia
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
To assess the application of partially randomized patient preference (PRPP) trial model which concerns the patients' preference on evaluation the therapeutic effect of non-pharmaceutical therapy, and ...
Eligibility Criteria
Inclusion
- Patients with fibromyalgia diagnosed according to criteria formulated by American College Rheumatology 2002;
- Patients whose scores for pain intensity is more than 30mm;
- Patients who are 20 to 60 years old;
- Patients who fully understand the process of this research and who are willing to provide informed consent.
Exclusion
- The widespread muscular-skeletal pain is caused by some kind of disease, surgery, or other external interference factors (except fibromyalgia);
- Patients with mental disorders, or other serious organic diseases, such as organ failure;
- Patients who take oral anodyne medications or accept other interventions for pain relief during the treatment;
- Pregnant or lactating women;
- Patients currently participating in another clinical trial.
Key Trial Info
Start Date :
July 23 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT01869712
Start Date
July 23 2013
End Date
December 31 2017
Last Update
July 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing University of Chinese Medicine Affiliated Dongfang Hospital
Beijing, Beijing Municipality, China, 100078